[en] Background: Parathyroid carcinoma (PCa) is rare and often difficult to differentiate initially from
benign disease. Because PCa oversecretes amino PTH that is detected by third-generation but not
by second-generation PTH assays, the normal generation PTH ( 1) is inverted in PCa (ie, 1).
Objective: The objective of the investigation was to study the utility and advantages of automated
generation PTH ratio measurements using the Liaison XL platform over existing manual
techniques.
Setting: The study was conducted at a tertiary-referral academic center.
Design: This was a retrospective laboratory study.
Subjects: Eleven patients with advanced PCa (mean age 56.0 y). The controls were patients with
1°-hyperparathyroidism (n 144;meanage 53.8 y), renal transplantation (n 41;meanage 50.6 y),
hemodialysis (n 80; mean age 65.2 y), and healthy elderly subjects (n 40; mean age 72.6 y).
Results: The median (interquartile range) generation PTH ratio was 1.16 (1.10 –1.38) in the PCa
group, which was significantly higher than the control groups: 0.74 (hemodialysis, 0.71–0.75), 0.77
(renal transplant, 0.73–0.79), 0.80 (healthy elderly, 0.74–0.83), and 0.76 (1°-hyperparathyroidism,
0.74–0.78). An inverted -generation PTH ratio ( 1) was seen in 9 of 11 PCa patients (81.8%) and
in 7 of 305 controls (2.3%), 3 of 80 hemodialysis (3.8%), and 4 of 144 1°-hyperparathyroidism
patients (2.8%). Of four PCa patients who had a normal PTH ratio with the manual method, two
had an inverted -generation PTH ratio with the automated method.
Conclusions: Study of the -generation PTH ratio in large patient populations should be feasible
using a mainstream automated platform like the Liaison XL. The current study confirms the utility
of the inverted -generation PTH ratio as a marker of PCa (sensitivity: 81.8%; specificity: 97.3%).
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
CAVALIER, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
BETEA, Daniela ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
SCHLECK, Marie-Louise ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs Biologie Clinique
GADISSEUR, Romy ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
VROONEN, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
DELANAYE, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
BECKERS, Albert ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Language :
English
Title :
The Third/Second Generation PTH Assay Ratio as a Marker for Parathyroid Carcinoma: Evaluation Using an Automated Platform
Publication date :
March 2014
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Thompson SD, Prichard AJ. The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2004;12(2):93-97. (Pubitemid 38420196)
Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-1129.
Schaapveld M, Jorna FH, Aben KK, Haak HR, Plukker JT, Links TP. Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis. Am J Surg. 2011;202(5):590-597.
Sharretts JM, Simonds WF. Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab. 2010; 24(3):491-502.
Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP. Parathyroid carcinoma. J Bone Miner Res. 2008; 23(12):1869-1880.
Grimelius L, Johansson H. Pathology of parathyroid tumors. Semin Surg Oncol. 1997;13(2):142-154. (Pubitemid 27146987)
Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15(6):738-744.
Schulte KM, Talat N. Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol. 2012;8(10):612-622.
D'Amour P, Brossard JH, Rousseau L, Roy L, Gao P, Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem. 2003;49(12):2037-2044. (Pubitemid 37449476)
Rubin MR, Silverberg SJ, D'Amour P, et al. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma. Clin Chem. 2007;53(8):1470-1476. (Pubitemid 47206343)
Caron P, Maiza JC, Renaud C, Cormier C, Barres BH, Souberbielle JC. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2009;70(4):533-538.
Rakel A, Brossard JH, Patenaude JV, et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clin Endocrinol (Oxf). 2005;62(6):721-727. (Pubitemid 40825943)
Cavalier E, Daly AF, Betea D, et al. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. J Clin Endocrinol Metab. 2010; 95(8):3745-3749.
Cavalier E, Carlisi A, Bekaert AC, Rousselle O, Chapelle JP, Delanaye P. New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clin Chim Acta. 2012;413(1-2):353-354.
Arakawa T, D'Amour P, Rousseau L, et al. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia. Clin J Am Soc Nephrol. 2006;1(3):525-531.
Tanaka M, Itoh K, Matsushita K, Matsushita K, Fujii H, Fukagawa M. Normalization of reversed bio-intact-PTH(1- 84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism. Clin Nephrol. 2005;64(1):69-72. (Pubitemid 40975068)
Komaba H, Takeda Y, Abe T, et al. Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient. Nephrol Dial Transplant. 2008;23(5):1760-1762. (Pubitemid 351767765)
Betea D, Bradwell AR, Harvey TC, Mead GP, Schmidt-Gayk H, Ghaye B, et al. Hormonal and biochemical normalization and tumor shrinkage induced by anti-parathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma. J Clin Endocrinol Metab. 2004;89:3413-3420. (Pubitemid 38951913)